STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #58 by analyst upside · 2026-06-27
CALC
CalciMedica, Inc.
Healthcare · Market Cap $13M · P/E 0x
ANALYST PRICE TARGET
+1166.5%
implied upside to consensus target
Current Price $0.82
Consensus Target $10.33
Bull Target $15.0
Bear Target $6.0
Analysts Covering 3
ANALYST CONSENSUS — BUY
Strong Buy
0
Buy
2
Hold
1
Sell
0
52-Week Low $0.46
52-Week High $7.2
YTD Return -87.9%
FUNDAMENTALS
Market Cap $13M
P/E Ratio (TTM) N/A
Forward P/E -0.5x
EPS (TTM) $-1.31
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) N/A
Profit Margin N/A
52-WEEK RANGE
52-Week Low $0.46
52-Week High $7.2
Current Price $0.82
Bear Target $6.0
Bull Target $15.0
● Now $0.82 ● Target $10.33
TRADING DATA
Avg Volume 1.2M
YTD Return -87.9%
Analyst Count 3
Consensus Buy
Upside to Target +1166.5%
Last Updated 2026-06-27

ANALYST SUMMARY

CalciMedica, Inc. (CALC) is currently trading at $0.82 with a Wall Street consensus price target of $10.33, implying potential upside of 1166.5% over the next 12 months. 3 analysts currently cover CALC, with a consensus rating of Buy — 67% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $15.0, while the most cautious has a target of $6.0.

CALC operates in the Healthcare sector with a market capitalisation of $13M. The stock is down 87.9% year-to-date and is currently trading near the lower end of its 52-week range of $0.46 – $7.2.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for CALC, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Oppenheimer — Reiterated
Outperform → Outperform 2026-03-05 14% win rate (7 calls)
HC Wainwright & Co. ↓ Downgrade
Buy → Neutral 2026-01-29 31% win rate (48 calls)
HC Wainwright & Co. reit
Buy → Buy 2025-05-15 31% win rate (48 calls)
HC Wainwright & Co. reit
Buy → Buy 2025-04-01 31% win rate (48 calls)
HC Wainwright & Co. reit
Buy → Buy 2025-03-04 31% win rate (48 calls)
LUCID CAPITAL MARKETS ● Initiated
Buy 2024-12-17 40% win rate (5 calls)
HC Wainwright & Co. reit
Buy → Buy 2024-11-14 31% win rate (48 calls)
HC Wainwright & Co. — Reiterated
Buy → Buy 2024-11-04 31% win rate (48 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
25
out of 100
Coverage depth
11/30
Consensus clarity
0/30
Vote unanimity
12/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →